Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo

被引:21
|
作者
Carome, MA
Kang, YH
Bohen, EM
Nicholson, DE
Carr, FE
Kiandoli, LC
Brummel, SE
Yuan, CM
机构
[1] WALTER REED ARMY MED CTR,SERV NEPHROL,WASHINGTON,DC 20307
[2] WALTER REED ARMY MED CTR,DEPT MED,ENDOCRINE SERV,WASHINGTON,DC 20307
[3] USN,MED RES INST,DIV PATHOL,BETHESDA,MD
来源
NEPHRON | 1997年 / 75卷 / 01期
关键词
phosphorothioate oligonucleotide; antisense; rat kidney; gene therapy; autoradiography;
D O I
10.1159/000189504
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Previous animal studies have demonstrated that following systemic administration phosphorothioate oligodeoxynucleotides (S-ODNs) are primarily excreted by the kidneys and that renal tissue levels of S-ODNs exceed that of other organs, Thus, the kidney may be an ideal target organ for application of antisense S-ODNs in vivo, We examined which cells within the rat kidney have uptake of radiolabeled S-ODNs following intravenous infusion. A 20-base S-35-ODN was infused into 6 adult male Wistar rats. Three animals each were sacrificed 30 min and 4 h after infusion. The kidneys were then removed, fixed, and tissue autoradiography was performed. Similar results were obtained in both groups, The highest level of radioactivity was seen within the proximal tubules. Lower levels of activity were seen within the glomerulus, the parietal epithelial cells of Bowman's space, and distal tubular cells, Very weak activity was also detected within the cells of the loop of Henle and the medullary collecting ducts. These results demonstrated that within the kidney S-ODNs were taken up primarily by proximal tubular cells, with much lower uptake by cells in other segments of the nephron.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 50 条
  • [41] Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice
    Zhao, QY
    Zhou, RZ
    Temsamani, J
    Zhang, ZW
    Roskey, A
    Agrawal, S
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (06): : 451 - 458
  • [42] Uptake of teicoplanin by isolated rat hepatocytes: Comparison with in vivo hepatic distribution
    Reinoso, RF
    Telfer, BA
    Brennan, BS
    Rowland, M
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (04) : 453 - 459
  • [43] MECHANISM OF UPTAKE OF VITAMIN-B12 BY KIDNEY OF RAT IN-VIVO
    NEWMARK, PA
    BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 261 (01) : 85 - &
  • [44] End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides
    Hebb, MO
    Robertson, HA
    MOLECULAR BRAIN RESEARCH, 1997, 47 (1-2): : 223 - 228
  • [45] Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver
    Theilig, F
    Bostanjoglo, M
    Pavenstädt, H
    Grupp, C
    Holland, G
    Slosarek, I
    Gressner, AM
    Russwurm, M
    Koesling, D
    Bachmann, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (11): : 2209 - 2220
  • [46] THE DISTRIBUTION OF RADIOLABELED PHOSPHOROTHIOATE OLIGONUCLEOTIDES (S-ODNS) WITHIN THE RAT-KIDNEY FOLLOWING INTRAVENOUS ADMINISTRATION
    CAROME, MA
    KANG, YH
    BOHEN, EM
    NICHOLSON, DE
    CARR, FE
    YUAN, CM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 618 - 618
  • [47] CELLULAR UPTAKE AND BIOLOGIC EFFICACY OF PHOSPHODIESTER, PHOSPHOROTHIOATE, AND CHIMERIC OLIGODEOXY-NUCLEOTIDES
    KRIEG, AM
    ZHAO, QY
    MATSON, S
    HERRARA, CJ
    FISHER, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 193 - 193
  • [48] DIGOXIGENIN-LABELED PHOSPHOROTHIOATE OLIGONUCLEOTIDES - A NEW TOOL FOR THE STUDY OF CELLULAR UPTAKE
    TARRASON, G
    BELLIDO, D
    ERITJA, R
    VILARO, S
    PIULATS, J
    ANTISENSE RESEARCH AND DEVELOPMENT, 1995, 5 (03): : 193 - 201
  • [49] INVIVO DETERMINATION OF CELLULAR UPTAKE IN THE KIDNEY
    SILVERMAN, M
    TRAINOR, C
    FEDERATION PROCEEDINGS, 1982, 41 (14) : 3054 - 3060
  • [50] CHOLESTERYL-CONJUGATED PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES MODULATE CYP2B1 EXPRESSION IN-VIVO
    DESJARDINS, J
    MATA, J
    BROWN, T
    GRAHAM, D
    ZON, G
    IVERSEN, P
    JOURNAL OF DRUG TARGETING, 1995, 2 (06) : 477 - 485